TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
24.25
-0.12 (-0.49%)
At close: Oct 22, 2024, 4:00 PM
24.00
-0.25 (-1.03%)
Pre-market: Oct 23, 2024, 7:00 AM EDT
TG Therapeutics Market Cap
TG Therapeutics has a market cap or net worth of $3.48 billion as of October 23, 2024. Its market cap has increased by 196.16% in one year.
Market Cap
3.48B
Enterprise Value
3.37B
1-Year Change
196.16%
Ranking
Category
Stock Price
$24.25
Market Cap Chart
Since May 3, 2010, TG Therapeutics's market cap has increased from $9.10M to $3.48B, an increase of 38,127.18%. That is a compound annual growth rate of 50.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2024 | 3.77B | 45.90% |
| Dec 29, 2023 | 2.59B | 50.41% |
| Dec 30, 2022 | 1.72B | -36.69% |
| Dec 31, 2021 | 2.72B | -60.29% |
| Dec 31, 2020 | 6.84B | 518.96% |
| Dec 31, 2019 | 1.11B | 225.13% |
| Dec 31, 2018 | 339.90M | -41.33% |
| Dec 29, 2017 | 579.30M | 127.62% |
| Dec 30, 2016 | 254.50M | -59.38% |
| Dec 31, 2015 | 626.60M | -10.02% |
| Dec 31, 2014 | 696.40M | 433.23% |
| Dec 31, 2013 | 130.60M | 43.20% |
| Dec 31, 2012 | 91.20M | 91,100.00% |
| Dec 30, 2011 | 100.00K | -97.92% |
| Dec 31, 2010 | 4.80M | -47.25% |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PROCEPT BioRobotics | 3.54B |
| Prestige Consumer Healthcare | 3.53B |
| Perrigo Company | 3.53B |
| Merus | 3.52B |
| HUTCHMED (China) | 3.51B |
| Dyne Therapeutics | 3.36B |
| Xenon Pharmaceuticals | 3.35B |
| Apellis Pharmaceuticals | 3.27B |